Interestingly, FoxA1 was found to be a downstream target of another transcription factor GATA3 [52] that has been used as a critical immunohistochemical marker for not only diagnosing breast cancer in surgical pathology practice but also urothelial differentiation [53]. Here, FOXA1 is linked to breast carcinoma.